688488 Jiangsu Aidea Pharmaceutical
- 9.28
- -0.06-0.64%
Jiangsu Aidea Pharmaceutical News
Eddy Pharmaceuticals: Eddy Pharmaceuticals Voluntary Disclosure Notice on Approval of the Marketing Application for New Indications of Enomie Tablets
Eddy Pharmaceuticals: Eddy Pharmaceuticals Progress Notice on Major Asset Restructurings
Addy Pharmaceuticals: Addy Pharmaceuticals Voluntary Disclosure Notice on Withdrawal of the Marketing Application for New Indications of Anovirin Tablets
Legal opinion of Jiangsu Century Tongren Law Firm on the implementation of major asset purchases of Jiangsu Eddy Pharmaceutical Co., Ltd.
Independent financial advisory opinion of Minsheng Securities Co., Ltd. on the implementation of major asset purchases by Jiangsu Eddy Pharmaceutical Co., Ltd.
Eddy Pharmaceuticals: Announcement of Resolutions of the 25th Meeting of the 2nd Board of Supervisors of Eddy Pharmaceuticals
Announcement of Resolutions of the 25th Meeting of the 2nd Board of Supervisors of Eddy Pharmaceuticals
Eddy Pharmaceuticals Announcement on Participating in the 2024 Semi-Annual Science and Technology Innovation Board Special Group Performance Briefing on Pharmaceuticals and Biological Products
Eddy Pharmaceutical\'s announcement on applying for bank credit lines
Eddy Pharmaceuticals Investor Relations Activity Record Form (2024-003)
Jiangsu Aidea Pharmaceutical Board of Directors' 2nd Session, 25th Meeting Resolution Announcement
Jiangsu Aidea Pharmaceutical Co., Ltd. Previous Fund Usage Verification Report
Jiangsu Aidea Pharmaceutical's Second Session of the Second Board of Supervisors Resolution Announcement
Jiangsu Aidea Pharmaceutical's explanation on the use of funds raised, which belongs to the field of technology innovation.
Special Report on the Deposit and Actual Use of Raised Funds in the First Half of 2024 by Jiangsu Aidea Pharmaceutical
Special Report on the Use of Previous Fundraising by Jiangsu Aidea Pharmaceutical
The semi-annual evaluation report on the "Improving Quality and Efficiency for Return" action plan for the company in 2024 of Jiangsu Aidea Pharmaceutical.
Jiangsu Aidea Pharmaceutical Announcement on Recent Five Years of Punishment or Regulatory Measures by Securities Regulatory Agencies and Stock Exchanges
Minsheng Securities Co., Ltd.'s independent financial advisor verification opinion on self-examination report on insider trading of Jiangsu Aidea Pharmaceutical Co., Ltd.'s stock transactions
Special inspection opinion on the self-examination report of insiders' trading of stocks related to the major asset purchase of Jiangsu Aidea Pharmaceutical Co., Ltd. by Jiangsu Century Tongren Law Firm
Analysis
Price Target
No Data
No Data